FDA Authorizes Emergency Use of Anti-Malaria Drugs for COVID-19 Patients

On Sunday , the Food and Drug Administration (FDA) authorized emergency-use for two anti-malaria drugs that health officials believe may help combat COVID-19 coronavirus.

The Department of Health and Human Services (HHS) issued a statement that the authorization will allow a donation of 30 million doses of hydroxychloroquine sulfate and 1 million doses of chloroquine phosphate to the Strategic National Stockpile.

HHS also stated that the products will be "distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible."

The Hill reports:

President Trump has repeatedly touted the anti-malaria drugs as a possible coronavirus "game changer," despite warnings from health officials that not enough is known about their effects on COVID-19. Dr. Anthony Fauci, the government’s top infectious disease expert, said during a press briefing earlier this month that much of what is known about the drug is based on "anecdotal reports."

"It was not done in a controlled clinical trial, so you really can’t make any definitive statement about it," he said. 

Hydroxychloroquine sulfate and chloroquine phosphate are oral prescription drugs typically used to treat malaria and other diseases, HHS noted. The department acknowledged that there are no approved treatments for COVID-19 but said that "both drugs have shown activity in laboratory studies against coronaviruses."

The department said that clinical trials are still needed to "provide scientific evidence that these treatments are effective." 

"Scientists in America and around the world have identified multiple potential therapeutics for #COVID19, including chloroquine and hydroxychloroquine," HHS Secretary Alex Azar tweeted. "Trump is taking every possible step to protect Americans from the coronavirus and provide them with hope."

 

Trending Political News

Kathy Griffin Hospitalized and Refused Coronavirus – Test Blames President Trump, Later Learns She Had This

Kathy Griffin is not just a washed-up comedian, but also a very very very outspoken anti-Trumper. I never thought that she was funny, and I don't think many people did which is why she's a nobody now.

Griffin was hospitalized last week with what she says were "unbearably painful" symptoms.

Continue reading...

WATCH: Chaos On House Floor As Democrats Melt Down During Coronavirus Bill Debate

Sometimes it blows my mind how absolutely crazy Democrats are.

I really mean it. They are consciously lying on a daily basis, slandering other elected officials.

Continue reading…

CNN Jake Tapper ADMITS He Allowed Ocasio-Cortez To Lie About President Trump

Recently after an interview with Rep. Alexandria Ocasio-Cortez, Jake Tapper admitted that he allowed AOC to lie about President Trump and even thought about saying something about it, but didn't.

AOC said, "The beds and the capacity that we need in this country. And we're hearing it every step of the way from this administration. First, we were hearing that it's a hoax, then we were hearing that everything was fine."

Continue reading…

Trump Discovered Elizabeth Warren STOLE $5 Billion...Where She Spent It Will Have You Furious

Before Donald Trump was even sworn in as President of the United States back in 2016, the Democrats were already focused on the mission of getting him impeached and removed from office.

They knew his mission. They knew that he would be working tirelessly to drain the swamp and clean the corruption out of Washington.

Continue reading…

‘She’s A Sick Puppy’: Trump Blasts Pelosi’s Critique Of His Coronavirus Response

President Trump on Monday ripped House Speaker Nancy Pelosi’s claim that the White House has bungled the response to coronavirus.

“As the president fiddles, people are dying,” Pelosi said Sunday on CNN’s “State of the Union.”

Continue reading…

Johnson & Johnson: We Have Lead Vaccine Candidate For Coronavirus, Hope For One Billion Vaccines Worldwide

On Monday, Johnson & Johnson announced they had selected a lead COVID-19 vaccine candidate to help fight the virus.

The company stated they had been working on various candidates for a vaccine since January; the goal is to provide a global supply of more than one billion doses. The company expects to conduct human clinical studies of its lead vaccine candidate at the latest by September 2020 and estimates it could start delivering the vaccine by early 2021, which it notes is “a substantially accelerated timeframe in comparison to the typical vaccine development process.”

Continue reading...